Touchon J

Title : Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials - Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201

Author(s) : Yu JT , Xu W , Tan CC , Andrieu S , Suckling J , Evangelou E , Pan A , Zhang C , Jia J , Feng L , Kua EH , Wang YJ , Wang HF , Tan MS , Li JQ , Hou XH , Wan Y , Tan L , Mok V , Dong Q , Touchon J , Gauthier S , Aisen PS , Vellas B

Ref : Journal of Neurology Neurosurg Psychiatry , 91 :1201 , 2020

Abstract : Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201

ESTHER : Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201

PubMedSearch : Yu_2020_J.Neurol.Neurosurg.Psychiatry_91_1201

PubMedID: 32690803

Title : Exploring sleep-related outcomes in patients with mild to moderate Alzheimer's disease initiating acetylcholinesterase inhibitor therapy: the Morpheus survey -

Author(s) : Petiau C , Onen H , Delgado A , Touchon J

Ref : Int J Geriatr Psychiatry , 28 :657 , 2013

PubMedID: 23649861

Title : Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease -

Author(s) : Touchon J , Vellas B , Katchaturian Z

Ref : J Nutr Health Aging , 13 :204 , 2009

PubMedID: 19262952

Title : Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials? - Cortes_2007_J.Nutr.Health.Aging_11_330

Author(s) : Cortes F , Portet F , Touchon J , Vellas B

Ref : J Nutr Health Aging , 11 :330 , 2007

Abstract : Cortes_2007_J.Nutr.Health.Aging_11_330

ESTHER : Cortes_2007_J.Nutr.Health.Aging_11_330

PubMedSearch : Cortes_2007_J.Nutr.Health.Aging_11_330

PubMedID: 17653493

Title : [Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease] - Ollat_2007_Encephale_33_211

Author(s) : Ollat H , Laurent B , Bakchine S , Michel BF , Touchon J , Dubois B

Ref : Encephale , 33 :211 , 2007

Abstract : Ollat_2007_Encephale_33_211

ESTHER : Ollat_2007_Encephale_33_211

PubMedSearch : Ollat_2007_Encephale_33_211

PubMedID: 17675917

Title : Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease - Dujardin_2006_J.Neurol_253_1154

Author(s) : Dujardin K , Devos D , Duhem S , Destee A , Marie RM , Durif F , Lacomblez L , Touchon J , Pollak P , Pere JJ

Ref : Journal of Neurology , 253 :1154 , 2006

Abstract : Dujardin_2006_J.Neurol_253_1154

ESTHER : Dujardin_2006_J.Neurol_253_1154

PubMedSearch : Dujardin_2006_J.Neurol_253_1154

PubMedID: 16998649

Title : Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease - Bullock_2006_Curr.Med.Res.Opin_22_483

Author(s) : Bullock R , Bergman H , Touchon J , Gambina G , He Y , Nagel J , Lane R

Ref : Curr Med Res Opin , 22 :483 , 2006

Abstract : Bullock_2006_Curr.Med.Res.Opin_22_483

ESTHER : Bullock_2006_Curr.Med.Res.Opin_22_483

PubMedSearch : Bullock_2006_Curr.Med.Res.Opin_22_483

PubMedID: 16574032

Title : Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study - Ancelin_2006_BMJ_332_455

Author(s) : Ancelin ML , Artero S , Portet F , Dupuy AM , Touchon J , Ritchie K

Ref : BMJ , 332 :455 , 2006

Abstract : Ancelin_2006_BMJ_332_455

ESTHER : Ancelin_2006_BMJ_332_455

PubMedSearch : Ancelin_2006_BMJ_332_455

PubMedID: 16452102

Title : Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period - Bullock_2005_Curr.Med.Res.Opin_21_1317

Author(s) : Bullock R , Touchon J , Bergman H , Gambina G , He Y , Rapatz G , Nagel J , Lane R

Ref : Curr Med Res Opin , 21 :1317 , 2005

Abstract : Bullock_2005_Curr.Med.Res.Opin_21_1317

ESTHER : Bullock_2005_Curr.Med.Res.Opin_21_1317

PubMedSearch : Bullock_2005_Curr.Med.Res.Opin_21_1317

PubMedID: 16083542

Title : No additional benefit of HRT on response to rivastigmine in menopausal women with AD -

Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ

Ref : Neurology , 60 :148 , 2003

PubMedID: 12525745

Title : [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study] - Rigaud_2003_Presse.Med_32_1649

Author(s) : Rigaud AS , Andre G , Vellas B , Touchon J , Pere JJ , Loria-Kanza Y

Ref : Presse Med , 32 :1649 , 2003

Abstract : Rigaud_2003_Presse.Med_32_1649

ESTHER : Rigaud_2003_Presse.Med_32_1649

PubMedSearch : Rigaud_2003_Presse.Med_32_1649

PubMedID: 14631268

Touchon J

References (11)

1. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

2. Exploring sleep-related outcomes in patients with mild to moderate Alzheimer's disease initiating acetylcholinesterase inhibitor therapy: the Morpheus survey

3. Editorial: CTAD International Research Conference: Clinical Trials in Alzheimer's Disease

4. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?

5. [Effects of the association of sulbutiamine with an acetylcholinesterase inhibitor in early stage and moderate Alzheimer disease]

6. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease

7. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease

8. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

9. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

10. No additional benefit of HRT on response to rivastigmine in menopausal women with AD

11. [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study]